Risk Factors, Clinical Characteristics, and Treatment Differences Between Residents With and Without Nursing Home- and Non-Nursing Home-Acquired <i>Clostridium difficile</i> Infection

201515 citationsJournal Articlebronze Open Access

Authors

Terrence O’Shea · Omnicare Pharma (Germany)

Marcie Strauss · Cubist Pharmaceuticals (United States)

Abstract

Residents with CDI had more comorbidities, and the NNH-Acquired group bore a higher burden of illness, resulting in differing treatment patterns and outcomes than the NH-Acquired CDI group.

Topics & Keywords

Clostridium difficile and Clostridium perfringens research Microscopic Colitis Nosocomial Infections in ICU

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Managed Care & Specialty Pharmacy

Volume 21, Issue 7, pp. 585-595

DOI: 10.18553/jmcp.2015.21.7.585

Field-Weighted Citation Impact: 1.15